> top > projects > sonoma > docs > PubMed:22966071 > annotations
sonoma  

PubMed:22966071 JSONTXT 6 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T-0 0-44 GENE denotes Sterol regulatory element-binding protein-1c
T-1 54-62 POSREG denotes increase
T-2 66-91 MPA denotes postprandial stearic acid
T-3 116-125 POSREG denotes improving
T-4 126-144 MPA denotes insulin resistance
T-5 149-163 MPA denotes hyperlipidemia
T-6 165-173 POSREG denotes Elevated
T-7 174-203 MPA denotes serum free fatty acids (FFAs)
T-8 219-233 REG denotes important role
T-9 256-274 MPA denotes insulin resistance
T-10 276-278 MPA denotes IR
T-11 284-292 DISEASE denotes diabetes
T-12 386-389 MPA denotes FFA
T-13 401-421 MPA denotes hyperlipidemia (HLP)
T-14 446-465 MPA denotes insulin sensitivity
T-15 505-528 MPA denotes serum stearic acid (SA)
T-16 560-569 POSREG denotes increased
T-17 614-623 POSREG denotes elevation
T-18 627-629 MPA denotes SA
T-19 633-636 REG denotes due
T-20 640-649 POSREG denotes increased
T-21 650-686 MPA denotes insulin-stimulated de novo synthesis
T-22 717-858 PATHWAY denotes element-binding protein-1c (SREBP-1c)/acetyl-CoA carboxylase/fatty acid synthase/elongation of long-chain fatty acid family member 6 (ELOVL6)
T-23 867-877 POSREG denotes elongation
T-24 881-894 MPA denotes palmitic acid
T-25 896-898 MPA denotes PA
T-26 913-919 GENE denotes ELOVL6
T-27 921-935 NEGREG denotes Downregulation
T-28 939-947 GENE denotes SREBP-1c
T-29 951-957 GENE denotes ELOVL6
T-30 961-982 MPA denotes small interfering RNA
T-31 987-993 NEGREG denotes reduce
T-32 994-1006 MPA denotes SA synthesis
T-33 1026-1034 MPA denotes SA level
T-34 1048-1060 POSREG denotes amelioration
T-35 1064-1066 MPA denotes IR
T-36 1070-1073 MPA denotes HLP
T-37 1089-1099 NEGREG denotes inhibition
T-38 1103-1111 GENE denotes SREBP-1c
T-39 1133-1142 POSREG denotes improving
T-40 1143-1145 MPA denotes IR
T-41 1151-1162 NEGREG denotes suppression
T-42 1166-1172 GENE denotes ELOVL6
T-43 1180-1188 REG denotes resulted
T-44 1192-1210 MPA denotes accumulation of PA
T-45 1224-1233 POSREG denotes increased
T-46 1247-1249 MPA denotes SA
T-47 1253-1259 REG denotes caused
T-48 1286-1302 PATHWAY denotes SREBP-1c pathway
T-49 1307-1317 POSREG denotes elongation
T-50 1321-1323 MPA denotes PA
T-51 1327-1330 MPA denotes HLP
T-52 1332-1341 NEGREG denotes Reduction
T-53 1358-1360 MPA denotes SA
T-54 1385-1394 POSREG denotes improving
T-55 1395-1397 MPA denotes IR
T-56 1403-1411 GENE denotes SREBP-1c
T-57 1429-1442 POSREG denotes better target
T-58 1454-1456 MPA denotes IR
T-59 1461-1469 DISEASE denotes diabetes
T-60 1473-1483 NEGREG denotes decreasing
T-61 1484-1486 MPA denotes SA
R-0 T-2 T-1 ThemeOf postprandial stearic acid,increase
R-1 T-2 T-4 CauseOf postprandial stearic acid,insulin resistance
R-10 T-44 T-43 ThemeOf accumulation of PA,resulted
R-11 T-46 T-45 ThemeOf SA,increased
R-12 T-46 T-47 ThemeOf SA,caused
R-13 T-17 T-19 ThemeOf elevation,due
R-14 T-49 T-47 CauseOf elongation,caused
R-15 T-49 T-45 ThemeOf elongation,increased
R-16 T-50 T-49 ThemeOf PA,elongation
R-17 T-52 T-54 CauseOf Reduction,improving
R-18 T-53 T-52 ThemeOf SA,Reduction
R-19 T-53 T-54 ThemeOf SA,improving
R-2 T-37 T-39 CauseOf inhibition,improving
R-20 T-58 T-60 ThemeOf IR,decreasing
R-21 T-58 T-57 ThemeOf IR,better target
R-22 T-61 T-60 ThemeOf SA,decreasing
R-23 T-26 T-23 ThemeOf ELOVL6,elongation
R-24 T-20 T-19 CauseOf increased,due
R-25 T-20 T-17 CauseOf increased,elevation
R-26 T-0 T-1 ThemeOf Sterol regulatory element-binding protein-1c,increase
R-27 T-0 T-2 CauseOf Sterol regulatory element-binding protein-1c,postprandial stearic acid
R-28 T-0 T-4 CauseOf Sterol regulatory element-binding protein-1c,insulin resistance
R-29 T-4 T-3 ThemeOf insulin resistance,improving
R-3 T-37 T-43 CauseOf inhibition,resulted
R-30 T-5 T-4 ThemeOf hyperlipidemia,insulin resistance
R-31 T-7 T-6 ThemeOf serum free fatty acids (FFAs),Elevated
R-32 T-7 T-8 ThemeOf serum free fatty acids (FFAs),important role
R-33 T-8 T-9 ThemeOf important role,insulin resistance
R-34 T-8 T-10 ThemeOf important role,IR
R-35 T-8 T-11 ThemeOf important role,diabetes
R-36 T-27 T-34 CauseOf Downregulation,amelioration
R-37 T-27 T-31 CauseOf Downregulation,reduce
R-38 T-13 T-12 ThemeOf hyperlipidemia (HLP),FFA
R-39 T-14 T-12 ThemeOf insulin sensitivity,FFA
R-4 T-18 T-17 ThemeOf SA,elevation
R-40 T-21 T-20 ThemeOf insulin-stimulated de novo synthesis,increased
R-41 T-24 T-23 ThemeOf palmitic acid,elongation
R-42 T-25 T-23 ThemeOf PA,elongation
R-43 T-23 T-17 CauseOf elongation,elevation
R-44 T-30 T-27 CauseOf small interfering RNA,Downregulation
R-45 T-32 T-31 ThemeOf SA synthesis,reduce
R-46 T-33 T-31 ThemeOf SA level,reduce
R-47 T-40 T-39 ThemeOf IR,improving
R-48 T-22 T-17 CauseOf element-binding protein-1c (SREBP-1c)/acetyl-CoA carboxylase/fatty acid synthase/elongation of long-chain fatty acid family member 6 (ELOVL6),elevation
R-49 T-22 T-19 CauseOf element-binding protein-1c (SREBP-1c)/acetyl-CoA carboxylase/fatty acid synthase/elongation of long-chain fatty acid family member 6 (ELOVL6),due
R-5 T-18 T-19 ThemeOf SA,due
R-50 T-15 T-16 ThemeOf serum stearic acid (SA),increased
R-51 T-48 T-45 CauseOf SREBP-1c pathway,increased
R-52 T-48 T-47 CauseOf SREBP-1c pathway,caused
R-53 T-51 T-50 ThemeOf HLP,PA
R-54 T-55 T-54 ThemeOf IR,improving
R-55 T-56 T-57 ThemeOf SREBP-1c,better target
R-56 T-56 T-60 CauseOf SREBP-1c,decreasing
R-57 T-28 T-27 ThemeOf SREBP-1c,Downregulation
R-58 T-29 T-27 ThemeOf ELOVL6,Downregulation
R-59 T-35 T-34 ThemeOf IR,amelioration
R-6 T-38 T-37 ThemeOf SREBP-1c,inhibition
R-60 T-36 T-34 ThemeOf HLP,amelioration
R-61 T-59 T-57 ThemeOf diabetes,better target
R-62 T-59 T-60 ThemeOf diabetes,decreasing
R-7 T-41 T-39 CauseOf suppression,improving
R-8 T-41 T-43 CauseOf suppression,resulted
R-9 T-42 T-41 ThemeOf ELOVL6,suppression